조혈모세포이식 환자에서 침습성 진균 감염에 대한이트라코나졸 액과 플루코나졸 시럽의 예방 효과 :전향적, 무작위, 비교 임상시험

참고문헌 (24)

1. "Antifungal chemoprophylaxis after blood and marrow transplantation", 34, pp.1386~90 (2002)
2. "A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation", 326, pp.845~51 (1992)
3. "Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation a prospective,randomized,double-blind study", 171, pp.1545~52 (1995)
4. "Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients", 19, pp.801~8 (1997)
5. "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients", 34, pp.909~17 (2002)
6. "Choices aplenty:antifungal prophylaxis in hematopoietic stem cell transplant recipients", 34, pp.377~89 (2004)
7. "A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies", 105, pp.901~1 (1999)
8. "Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia", 44, pp.1887~33 (2000), multicenter trial comparing itraconazole and amphotericin B
9. "Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients", 138, pp.705~13 (2003), a multicenter
10. "Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies", 28, pp.250~5 (1999), multicenter trial
11. "2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer", 34, pp.730~51 (2002)
12. "Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants"
13. "of the German Society of Hematology and Oncology Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors-guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Oncology", 82(22), pp.186~200 (2003)
14. "Analysis of invasive fungal infection after hematopoietic stem cell transplantation or chemotherapy in patients with hematologic diseases", 36, pp.40~5 (2004)
15. "Aspergillus Study Group:Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients", 48, pp.198~206 (2001)
16. "Clinical experience with itraconazole in systemic fungal infections", 61, pp.39~47 (2001)
17. "Current and emerging azole antifungal agents", 12, pp.40~79 (1999)
18. "Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients", 34, pp.247~52 (1994)
19. "Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation", 21, pp.1239~43 (1998)
20. "Antifungal prophylaxis with itraconazole in prolonged neutropenia correlation with plasma levels", 32, pp.103~8 (1989)
21. "Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants", 103, pp.1527~33 (2004)
22. "Cyclophosphamide metabolism is affected by azole antifungals", 103, pp.1557~9 (2004)
23. "The effect of fluconazole on cyclophosphamide metabolism in children", 27, pp.417~21 (1999)
24. "Cyclophosphamide metabolism,liver toxicity,and mortality following hematopoietic stem cell transplantation", 101, pp.2043~8 (2003)

관련 논문AI추천